Discontinued — last reported Q1 '24
Smart Dose — Deferred income
West Pharmaceutical Services Smart Dose — Deferred income decreased by 13.6% to $1.90M in Q1 2024 compared to the prior quarter. Year-over-year, this metric declined by 32.1%, from $2.80M to $1.90M. Over 2 years (FY 2021 to FY 2023), Smart Dose — Deferred income shows a downward trend with a -22.8% CAGR.
Analysis
How to read this metric
An increase suggests strong future demand and a growing pipeline of contracted work, while a decrease may indicate the fulfillment of obligations or a slowdown in new contract signings.
Detailed definition
Represents the total liability for payments received from customers for Smart Dose platform services or products that ha...
Peer comparison
Similar to deferred revenue or contract liabilities found in other medical device or pharmaceutical technology companies with long-term service agreements.
wst_segment_smart_dose_deferred_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.30M | $4.10M | $3.90M | $3.70M | $3.40M | $3.20M | $3.00M | $2.80M | $2.60M | $2.40M | $2.20M | $1.90M |
| QoQ Change | — | -4.7% | -4.9% | -5.1% | -8.1% | -5.9% | -6.3% | -6.7% | -7.1% | -7.7% | -8.3% | -13.6% |
| YoY Change | — | — | — | — | -20.9% | -22.0% | -23.1% | -24.3% | -23.5% | -25.0% | -26.7% | -32.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's smart dose — deferred income?
- West Pharmaceutical Services (WST) reported smart dose — deferred income of $1.90M in Q1 2024.
- How has West Pharmaceutical Services's smart dose — deferred income changed year-over-year?
- West Pharmaceutical Services's smart dose — deferred income decreased by 32.1% year-over-year, from $2.80M to $1.90M.
- What is the long-term trend for West Pharmaceutical Services's smart dose — deferred income?
- Over 2 years (2021 to 2023), West Pharmaceutical Services's smart dose — deferred income has grown at a -22.8% compound annual growth rate (CAGR), from $16.80M to $10.00M.
- What does smart dose — deferred income mean?
- The total amount of money received from customers for Smart Dose services that has not yet been earned as revenue.